Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Neuro-Oncology Practice|June 3, 2015
Personal health records, symptoms, uncertainty, and mood in brain tumor patientsJennifer E Cahill, Lin Lin, Geri LoBiondo-Wood, et al.
Neuro-Oncology|April 12, 2015
The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-ChronicTerri S Armstrong, Yuan Ying, Jimin Wu, et al.
Neuro-Oncology Practice|August 7, 2019
Survivorship care planning in neuro-oncologyHeather E Leeper, Alvina A Acquaye, Susan Bell, et al.
Neuro-Oncology Practice|May 23, 2022
Assessing mobility in primary brain tumor patients: A descriptive feasibility study using two established mobility testsJames L Rogers, Julianie De La Cruz Minyety, Elizabeth Vera, et al.
Journal of Neuro-Oncology|July 25, 2020
Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor SectionJohn Lynes, Alvina A Acquaye, Hannah Sur, et al.
Neuro-Oncology Practice|August 7, 2019
Association of genetic variants with fatigue in patients with malignant gliomaTerri S Armstrong, Elizabeth Vera, Renke Zhou, et al.
Cancer Medicine|February 15, 2025
Social Determinants of Health Predict Sleep-Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross-Sectional AnalysisMichelle L Wright, Hope Miller, Elizabeth Vera, et al.
Neuro-Oncology Practice|February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendationsAmanda L King, Kayla N Roche, Elizabeth Vera, et al.
Neuro-Oncology Practice|November 17, 2022
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patientsAmanda L King, Dorela D Shuboni-Mulligan, Elizabeth Vera, et al.
Research Square|February 15, 2023
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trialAmanda L King, Kayla N Roche, Heather E Leeper, et al.
Pageof 3